Intellectual Property
Selected issued patents
Dr. Damaj is a named inventor on approximately 75 issued and pending patents spanning nutraceuticals, natural product formulations, pharmaceutical therapeutics, and oncology. A representative selection is shown below.
Natural Products
Olive tree biomass extract
US 2023/0270325 A1 · United States · 2023
Cardiovascular Support
Oral compositions comprising monacolin(s) and uses thereof
US 11,958,589 B2 · United States · Granted 2024
Topical Therapeutics
Synergistically effective combination of lidocaine and chlorhexidine and uses thereof
US 2023/0044495 A1 · United States · 2023
Oncology
Methods to inhibit tumor cell growth by using protein kinase inhibitors
US 2011/0268807 A1 · United States · 2011
Antimicrobial
Methods of activating an anti-microbial function using amavadine
US 7,541,054 B2 · United States · Granted 2009
Diagnostics
Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as capture and detection agent
US 6,440,889 B1 · United States · Granted 2002
A note on this page. The publications and patents shown here are a representative selection. Complete lists are available upon request for regulatory and compliance reasons. Research referenced on this page reflects Dr. Damaj's scientific career and does not constitute a claim about any specific R&D Healthcare Canada product. Product-specific claims are governed by each product's Health Canada licence (NPN).